Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence
Authors:
- Angela IannicielloAIAngela Ianniciello
- Pierre-Yves DumasPDPierre-Yves Dumas
- Claire DrullionCDClaire Drullion
- Amélie GuitartAGAmélie Guitart
- Arnaud VillacrecesAVArnaud Villacreces
- Philippe Brunet de la GrangePGPhilippe Brunet de la Grange
- Isabelle VigonIVIsabelle Vigon
- Muriel PriaultMPMuriel Priault
- Persio Dello SbarbaPSPersio Dello Sbarba
Open Access
- 30 June 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (57) , 96984-96992
Abstract
Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescenceKeywords
This publication has 42 references indexed in Scilit:
- Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescenceCell Death & Disease, 2012
- The autophagy protein Atg7 is essential for hematopoietic stem cell maintenanceJournal of Experimental Medicine, 2011
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1Nature Cell Biology, 2011
- Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activityJournal of Clinical Investigation, 2011
- mTOR regulation of autophagyFEBS Letters, 2010
- Targeted Activation of Innate Immunity for Therapeutic Induction of Autophagy and Apoptosis in Melanoma CellsCancer Cell, 2009
- Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cellsJournal of Clinical Investigation, 2009
- Hypoxia regulates TSC1/2–mTOR signaling and tumor suppression through REDD1-mediated 14–3–3 shuttlingGenes & Development, 2008
- Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxiaProceedings of the National Academy of Sciences, 2007
- Hypoxia Inhibits Protein Synthesis through a 4E-BP1 and Elongation Factor 2 Kinase Pathway Controlled by mTOR and Uncoupled in Breast Cancer CellsMolecular and Cellular Biology, 2006